nodes	percent_of_prediction	percent_of_DWPC	metapath
Etidocaine—Lidocaine—CYP2C18—prostate cancer	0.0372	0.297	CrCbGaD
Etidocaine—Lidocaine—EGFR—prostate cancer	0.0291	0.232	CrCbGaD
Etidocaine—Lidocaine—CYP3A5—prostate cancer	0.0245	0.196	CrCbGaD
Etidocaine—Lidocaine—CYP2A6—prostate cancer	0.0238	0.19	CrCbGaD
Etidocaine—Lidocaine—CYP3A4—prostate cancer	0.0106	0.0848	CrCbGaD
Etidocaine—SCN5A—L1CAM interactions—NRP1—prostate cancer	0.00935	0.0107	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—MYH14—prostate cancer	0.00932	0.0107	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—MYH14—prostate cancer	0.00932	0.0107	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—PLXNB1—prostate cancer	0.00808	0.00924	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—PLXNB1—prostate cancer	0.00808	0.00924	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—EPHB2—prostate cancer	0.00728	0.00832	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—EPHB2—prostate cancer	0.00728	0.00832	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—FOXA3—prostate cancer	0.00708	0.00809	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—FOXA3—prostate cancer	0.00708	0.00809	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—FARP2—prostate cancer	0.00707	0.00808	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—FARP2—prostate cancer	0.00707	0.00808	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	0.00693	0.00792	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—PAK6—prostate cancer	0.0067	0.00766	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—PAK6—prostate cancer	0.0067	0.00766	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—MYH14—prostate cancer	0.00665	0.00761	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—MYH14—prostate cancer	0.00665	0.00761	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—LAMC1—prostate cancer	0.00639	0.00731	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—LAMC1—prostate cancer	0.00639	0.00731	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—MYH14—prostate cancer	0.00632	0.00723	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—RRAS—prostate cancer	0.00613	0.007	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—RRAS—prostate cancer	0.00613	0.007	CbGpPWpGaD
Etidocaine—SCN2A—L1CAM interactions—ITGB3—prostate cancer	0.006	0.00686	CbGpPWpGaD
Etidocaine—SCN4A—L1CAM interactions—ITGB3—prostate cancer	0.006	0.00686	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—PLXNB1—prostate cancer	0.00577	0.00659	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—PLXNB1—prostate cancer	0.00577	0.00659	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—EZR—prostate cancer	0.0057	0.00651	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—EZR—prostate cancer	0.0057	0.00651	CbGpPWpGaD
Etidocaine—SCN5A—Cardiac Progenitor Differentiation—KDR—prostate cancer	0.00556	0.00636	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—PLXNB1—prostate cancer	0.00548	0.00626	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—NRP1—prostate cancer	0.00521	0.00596	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—NRP1—prostate cancer	0.00521	0.00596	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—EPHB2—prostate cancer	0.00519	0.00594	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—EPHB2—prostate cancer	0.00519	0.00594	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—FARP2—prostate cancer	0.00504	0.00576	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—FARP2—prostate cancer	0.00504	0.00576	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—EPHB2—prostate cancer	0.00493	0.00564	CbGpPWpGaD
Etidocaine—SCN5A—Cardiac Progenitor Differentiation—GSK3B—prostate cancer	0.00492	0.00562	CbGpPWpGaD
Etidocaine—SCN5A—Cardiac Progenitor Differentiation—INS—prostate cancer	0.00485	0.00555	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—FOXA3—prostate cancer	0.0048	0.00548	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—FARP2—prostate cancer	0.00479	0.00548	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—PAK6—prostate cancer	0.00478	0.00546	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—PAK6—prostate cancer	0.00478	0.00546	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—HSP90AB1—prostate cancer	0.00474	0.00542	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—HSP90AB1—prostate cancer	0.00474	0.00542	CbGpPWpGaD
Etidocaine—SCN5A—Cardiac Progenitor Differentiation—IGF1—prostate cancer	0.00469	0.00536	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—LAMC1—prostate cancer	0.00456	0.00521	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—LAMC1—prostate cancer	0.00456	0.00521	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—PAK6—prostate cancer	0.00454	0.00519	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—MYH14—prostate cancer	0.00451	0.00516	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—RRAS—prostate cancer	0.00437	0.005	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—RRAS—prostate cancer	0.00437	0.005	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.00437	0.00499	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—LAMC1—prostate cancer	0.00433	0.00495	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—PRNP—prostate cancer	0.00432	0.00493	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—PRNP—prostate cancer	0.00432	0.00493	CbGpPWpGaD
Etidocaine—SCN5A—Cardiac Progenitor Differentiation—FGF2—prostate cancer	0.00431	0.00493	CbGpPWpGaD
Etidocaine—SCN2A—L1CAM interactions—MAP2K1—prostate cancer	0.00416	0.00475	CbGpPWpGaD
Etidocaine—SCN4A—L1CAM interactions—MAP2K1—prostate cancer	0.00416	0.00475	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—RRAS—prostate cancer	0.00415	0.00475	CbGpPWpGaD
Etidocaine—SCN5A—L1CAM interactions—ITGB3—prostate cancer	0.00407	0.00465	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.00407	0.00465	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—EZR—prostate cancer	0.00406	0.00465	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—EZR—prostate cancer	0.00406	0.00465	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—PLXNB1—prostate cancer	0.00391	0.00447	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—EZR—prostate cancer	0.00386	0.00441	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.00377	0.00431	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—TH—prostate cancer	0.00374	0.00428	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—NRP1—prostate cancer	0.00372	0.00425	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—NRP1—prostate cancer	0.00372	0.00425	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—HNF1B—prostate cancer	0.00372	0.00425	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—HNF1B—prostate cancer	0.00372	0.00425	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—NRP1—prostate cancer	0.00353	0.00404	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.00353	0.00403	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—EPHB2—prostate cancer	0.00352	0.00403	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—FARP2—prostate cancer	0.00342	0.00391	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—HSP90AB1—prostate cancer	0.00338	0.00387	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—HSP90AB1—prostate cancer	0.00338	0.00387	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.00336	0.00384	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—AR—prostate cancer	0.00333	0.00381	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—PAK6—prostate cancer	0.00324	0.0037	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—HSP90AB1—prostate cancer	0.00321	0.00367	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—LAMC1—prostate cancer	0.00309	0.00353	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—PRNP—prostate cancer	0.00308	0.00352	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—PRNP—prostate cancer	0.00308	0.00352	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—MED12—prostate cancer	0.00303	0.00346	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—MED12—prostate cancer	0.00303	0.00346	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—RRAS—prostate cancer	0.00296	0.00339	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—PRNP—prostate cancer	0.00293	0.00335	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—IL10—prostate cancer	0.00291	0.00333	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—NCOA3—prostate cancer	0.0029	0.00331	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—NCOA3—prostate cancer	0.0029	0.00331	CbGpPWpGaD
Etidocaine—SCN2A—L1CAM interactions—SRC—prostate cancer	0.00289	0.0033	CbGpPWpGaD
Etidocaine—SCN4A—L1CAM interactions—SRC—prostate cancer	0.00289	0.0033	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—PRKCQ—prostate cancer	0.00288	0.00329	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—PRKCQ—prostate cancer	0.00288	0.00329	CbGpPWpGaD
Etidocaine—SCN5A—L1CAM interactions—MAP2K1—prostate cancer	0.00282	0.00322	CbGpPWpGaD
Etidocaine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—prostate cancer	0.00281	0.00322	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—EZR—prostate cancer	0.00276	0.00315	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.00269	0.00308	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—VAV3—prostate cancer	0.00264	0.00302	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—VAV3—prostate cancer	0.00264	0.00302	CbGpPWpGaD
Etidocaine—SCN2A—L1CAM interactions—EGFR—prostate cancer	0.00253	0.00289	CbGpPWpGaD
Etidocaine—SCN4A—L1CAM interactions—EGFR—prostate cancer	0.00253	0.00289	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—HNF1B—prostate cancer	0.00252	0.00288	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—NRP1—prostate cancer	0.00252	0.00288	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.00245	0.0028	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—NCOA2—prostate cancer	0.00242	0.00276	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—NCOA2—prostate cancer	0.00242	0.00276	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—HSP90AB1—prostate cancer	0.00229	0.00262	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—ITGB3—prostate cancer	0.00227	0.00259	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—ITGB3—prostate cancer	0.00227	0.00259	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—PRNP—prostate cancer	0.00209	0.00239	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—PRKCQ—prostate cancer	0.00206	0.00235	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—PRKCQ—prostate cancer	0.00206	0.00235	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—MED12—prostate cancer	0.00205	0.00235	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—NCOA1—prostate cancer	0.00204	0.00233	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—NCOA1—prostate cancer	0.00204	0.00233	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.002	0.00229	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—NCOA3—prostate cancer	0.00196	0.00224	CbGpPWpGaD
Etidocaine—SCN5A—L1CAM interactions—SRC—prostate cancer	0.00196	0.00224	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—FGF10—prostate cancer	0.00195	0.00223	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—FGF10—prostate cancer	0.00195	0.00223	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—PRKCQ—prostate cancer	0.00195	0.00223	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—RXRA—prostate cancer	0.00194	0.00221	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—RXRA—prostate cancer	0.00194	0.00221	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—KDR—prostate cancer	0.00193	0.0022	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—KDR—prostate cancer	0.00193	0.0022	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—VAV3—prostate cancer	0.00188	0.00215	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—VAV3—prostate cancer	0.00188	0.00215	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—VAV3—prostate cancer	0.00179	0.00205	CbGpPWpGaD
Etidocaine—SCN5A—L1CAM interactions—EGFR—prostate cancer	0.00171	0.00196	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—GSK3B—prostate cancer	0.0017	0.00195	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—GSK3B—prostate cancer	0.0017	0.00195	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—LPL—prostate cancer	0.00168	0.00192	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—LPL—prostate cancer	0.00168	0.00192	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—NCOA2—prostate cancer	0.00164	0.00187	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—ITGB3—prostate cancer	0.00162	0.00185	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—ITGB3—prostate cancer	0.00162	0.00185	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.00159	0.00182	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—MMP2—prostate cancer	0.00157	0.0018	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—MMP2—prostate cancer	0.00157	0.0018	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—MAP2K1—prostate cancer	0.00157	0.0018	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—MAP2K1—prostate cancer	0.00157	0.0018	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—ITGB3—prostate cancer	0.00154	0.00176	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.00152	0.00174	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—PPARA—prostate cancer	0.00148	0.00169	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—PPARA—prostate cancer	0.00148	0.00169	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.00147	0.00168	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—JAK2—prostate cancer	0.00143	0.00164	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—JAK2—prostate cancer	0.00143	0.00164	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—LEP—prostate cancer	0.0014	0.00161	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—LEP—prostate cancer	0.0014	0.00161	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—PRKCQ—prostate cancer	0.00139	0.00159	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—NCOA1—prostate cancer	0.00138	0.00158	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—ERBB2—prostate cancer	0.00138	0.00158	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—ERBB2—prostate cancer	0.00138	0.00158	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—KDR—prostate cancer	0.00138	0.00157	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—KDR—prostate cancer	0.00138	0.00157	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—EP300—prostate cancer	0.00136	0.00156	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—FGF10—prostate cancer	0.00132	0.00151	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—RXRA—prostate cancer	0.00131	0.0015	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—KDR—prostate cancer	0.00131	0.00149	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.00129	0.00148	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—VAV3—prostate cancer	0.00128	0.00146	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—GSK3B—prostate cancer	0.00122	0.00139	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—GSK3B—prostate cancer	0.00122	0.00139	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—INS—prostate cancer	0.0012	0.00137	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—INS—prostate cancer	0.0012	0.00137	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—MMP9—prostate cancer	0.00118	0.00135	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—MMP9—prostate cancer	0.00118	0.00135	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—CREBBP—prostate cancer	0.00118	0.00134	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—CREBBP—prostate cancer	0.00118	0.00134	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—GSK3B—prostate cancer	0.00116	0.00132	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—LPL—prostate cancer	0.00114	0.0013	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—MMP2—prostate cancer	0.00112	0.00128	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—MMP2—prostate cancer	0.00112	0.00128	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—MAP2K1—prostate cancer	0.00112	0.00128	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—MAP2K1—prostate cancer	0.00112	0.00128	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—ITGB3—prostate cancer	0.0011	0.00125	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—SRC—prostate cancer	0.00109	0.00125	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—SRC—prostate cancer	0.00109	0.00125	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—MMP2—prostate cancer	0.00107	0.00122	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—FGF2—prostate cancer	0.00107	0.00122	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—FGF2—prostate cancer	0.00107	0.00122	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—MAP2K1—prostate cancer	0.00107	0.00122	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—VEGFA—prostate cancer	0.00106	0.00121	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—VEGFA—prostate cancer	0.00106	0.00121	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—JAK2—prostate cancer	0.00102	0.00117	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—JAK2—prostate cancer	0.00102	0.00117	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—PPARA—prostate cancer	0.001	0.00115	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—ERBB2—prostate cancer	0.000984	0.00112	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—ERBB2—prostate cancer	0.000984	0.00112	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—JAK2—prostate cancer	0.000971	0.00111	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—EGFR—prostate cancer	0.000956	0.00109	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—EGFR—prostate cancer	0.000956	0.00109	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—LEP—prostate cancer	0.000952	0.00109	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—ERBB2—prostate cancer	0.000935	0.00107	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—KDR—prostate cancer	0.000933	0.00107	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—KRAS—prostate cancer	0.000903	0.00103	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—KRAS—prostate cancer	0.000903	0.00103	CbGpPWpGaD
Etidocaine—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000894	0.00102	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—CTNNB1—prostate cancer	0.000861	0.000984	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—CTNNB1—prostate cancer	0.000861	0.000984	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—MMP9—prostate cancer	0.000844	0.000965	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—MMP9—prostate cancer	0.000844	0.000965	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—GSK3B—prostate cancer	0.000824	0.000943	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—INS—prostate cancer	0.000813	0.00093	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—MMP9—prostate cancer	0.000802	0.000917	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—EP300—prostate cancer	0.0008	0.000915	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—EP300—prostate cancer	0.0008	0.000915	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—CREBBP—prostate cancer	0.000797	0.000911	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—SRC—prostate cancer	0.000778	0.00089	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—SRC—prostate cancer	0.000778	0.00089	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—MMP2—prostate cancer	0.000761	0.00087	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—MAP2K1—prostate cancer	0.00076	0.000869	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—VEGFA—prostate cancer	0.000758	0.000867	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—VEGFA—prostate cancer	0.000758	0.000867	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—STAT3—prostate cancer	0.000751	0.000858	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—STAT3—prostate cancer	0.000751	0.000858	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—SRC—prostate cancer	0.000739	0.000845	CbGpPWpGaD
Etidocaine—SCN2A—Axon guidance—IL6—prostate cancer	0.000735	0.00084	CbGpPWpGaD
Etidocaine—SCN4A—Axon guidance—IL6—prostate cancer	0.000735	0.00084	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—FGF2—prostate cancer	0.000723	0.000827	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—VEGFA—prostate cancer	0.00072	0.000823	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—TGFB1—prostate cancer	0.000696	0.000795	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—TGFB1—prostate cancer	0.000696	0.000795	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—JAK2—prostate cancer	0.000693	0.000792	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—EGFR—prostate cancer	0.000682	0.00078	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—EGFR—prostate cancer	0.000682	0.00078	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—ERBB2—prostate cancer	0.000667	0.000763	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—EGFR—prostate cancer	0.000648	0.000741	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—KRAS—prostate cancer	0.000644	0.000737	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—KRAS—prostate cancer	0.000644	0.000737	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—KRAS—prostate cancer	0.000612	0.0007	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—CTNNB1—prostate cancer	0.000584	0.000667	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—MMP9—prostate cancer	0.000572	0.000654	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—EP300—prostate cancer	0.000543	0.00062	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—SRC—prostate cancer	0.000528	0.000603	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—IL6—prostate cancer	0.000524	0.000599	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—IL6—prostate cancer	0.000524	0.000599	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—VEGFA—prostate cancer	0.000514	0.000587	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—STAT3—prostate cancer	0.000509	0.000582	CbGpPWpGaD
Etidocaine—SCN5A—Axon guidance—IL6—prostate cancer	0.000498	0.000569	CbGpPWpGaD
Etidocaine—SCN2A—Developmental Biology—AKT1—prostate cancer	0.000484	0.000553	CbGpPWpGaD
Etidocaine—SCN4A—Developmental Biology—AKT1—prostate cancer	0.000484	0.000553	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—TGFB1—prostate cancer	0.000472	0.000539	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—EGFR—prostate cancer	0.000462	0.000529	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—KRAS—prostate cancer	0.000437	0.000499	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—IL6—prostate cancer	0.000355	0.000406	CbGpPWpGaD
Etidocaine—SCN5A—Developmental Biology—AKT1—prostate cancer	0.000328	0.000375	CbGpPWpGaD
